Increased Fructose Concentrations in Blood and Urine in Patients With Diabetes
- 1 February 2002
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 25 (2), 353-357
- https://doi.org/10.2337/diacare.25.2.353
Abstract
OBJECTIVE—To investigate fructose metabolic changes in patients with diabetes. RESEARCH DESIGN AND METHODS—Serum and urinary fructose concentrations were determined in healthy subjects (n = 23) and in nondiabetic (n = 23) and diabetic patients (n = 26). Fructose was measured using our newly developed method, and 13C6-fructose was used as the internal standard. After adding sample to a fixed amount of internal standard, ion-exchange resins and high-performance liquid chromatography pretreatments were performed. Then, the amount of fructose in the sample was measured by gas chromatography-mass spectrometry. RESULTS—Serum fructose concentrations in patients with diabetes (12.0 ± 3.8 μmol/l) were significantly higher than those in healthy subjects (8.1 ± 1.0 μmol/l, P < 0.001) and nondiabetic patients (7.7 ± 1.6 μmol/l, P < 0.001), and daily urinary fructose excretion was significantly greater in patients with diabetes (127.8 ± 106.7 μmol/day) than in nondiabetic patients (37.7 ± 23.0 μmol/day, P < 0.001). In patients with diabetes (n = 20), serum fructose concentrations (8.6 ± 1.8 μmol/l, P < 0.001) and daily urinary fructose excretion (63.4 ± 63.8 μmol/day, P < 0.01) significantly decreased by week 2 after admission. CONCLUSIONS—The present results differed from those of previous studies in that we found that the serum and urinary fructose concentrations decreased rapidly, concomitant with an improvement in glycemia. Therefore, hyperglycemia was associated with increased serum and urinary fructose concentrations in patients with diabetes.This publication has 20 references indexed in Scilit:
- Hepatic Production of 1,5‐Anhydrofructose and 1,5‐Anhydroglucitol in Rat by the third Glycogenolytic PathwayJBIC Journal of Biological Inorganic Chemistry, 1996
- Common reabsorption system of 1,5-anhydro-d-glucitol, fructose, and mannose in rat renal tubuleBiochimica et Biophysica Acta (BBA) - General Subjects, 1996
- Mannose, mannitol, fructose and 1,5-anhydroglucitol concentrations measured by gas chromatography/mass spectrometry in blood plasma of diabetic patientsClinica Chimica Acta; International Journal of Clinical Chemistry, 1996
- Metabolic effects of troglitazone on fructose-induced insulin resistance in the ratDiabetes, 1994
- Energy expenditure and substrate metabolism after oral fructose in patients with cirrhosisJournal of Hepatology, 1993
- Increase in cardiac muscle fructose content in streptozotocin-induced diabetic ratsMetabolism, 1992
- Role of fructose in glycation and cross-linking of proteinsBiochemistry, 1988
- Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitorDiabetes, 1985
- DANGERS OF INTRAVENOUS FRUCTOSEThe Lancet, 1972
- The Concentrations of Fructose, Glucose and Lactate in the Splanchnic Blood Vessels of Rats Absorbing FructoseAnnals of Nutrition and Metabolism, 1971